Tele: 561.316.3330
Breaking Medical Device News

Thursday, September 23, 2021

HomeAdvanced Sterilization ProductsReprocessing N95 Masks With STERRAD: Protects Healthcare Workers in the Battle Against COVID-19

Reprocessing N95 Masks With STERRAD: Protects Healthcare Workers in the Battle Against COVID-19

The Company ADVANCED STERILIZATION PRODUCTS Thanks FDA for New Guidance to Expedite Solutions in Order to Protect the Public

Advanced Sterilization Products has qualified a new reprocessing protocol that can extend the lifespan of single-use N95 masks (respirators) utilizing STERRAD® Systems already available in most US hospitals and globally.

The evolution of the COVID-19 pandemic has created a mass shortage of N95 masks for healthcare professionals around the world. ASP qualified a protocol for reprocessing select N95 masks so hospitals can triple the lifespan of the mask using the STERRAD® Sterilizers already in healthcare facilities today to reprocess up to 480 masks per STERRAD® Sterilizer machine daily to help healthcare professionals combat the spread of coronavirus.

“We are a company dedicated to keeping people safe, so we are proud to bring forth this new protocol to help extend the functionality of mission-essential N95 masks at this critical time,” said Dominic Ivankovich, President of ASP. “We are committed to provide support to the medical community and continue to work closely with them to implement this new protocol to help keep our HCP heroes safer as they remain at the front-lines in the battle against COVID-19.”

All ASP sterilization systems and disinfectant solutions have been tested against enveloped viruses, the family of viruses that includes coronavirus, and have been demonstrated to be efficacious against those viruses. ASP’s new qualified protocol uses technology already in place in most hospitals to now reprocess certain N95 masks.

“ASP feels responsible to help discover solutions that will aid frontline responders to remain safe in fighting back this pandemic,” said Jeremy Yarwood, Vice President Research & Development, ASP. “The new FDA guidance has allowed us go public with our qualified solution quickly so we can join the effort to overcome shortages of personal protection equipment for healthcare workers worldwide.”

Visit asp.com for complete and up-to-date information on PPE reprocessing, instructions for use of the N95 reprocessing protocol, and 8 Things to consider before reprocessing N95 masks/respirators.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

By using this website you agree to accept Medical Device News Magazine Privacy Policy